Chronic Constipation Clinical Trial
Official title:
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide Administered Orally for 12 Weeks Followed by a 4-Week Randomized Withdrawal Period in Patients With Chronic Constipation
The objective of this trial is to determine the efficacy and safety of linaclotide administered to patients with chronic constipation (CC). The primary efficacy parameter is the percentage of patients in each dosing group that meet the protocol definition for Complete Spontaneous Bowel Movement (CSBM) Overall Responder.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05980988 -
Effectiveness and Safety of Probiotic in Regulating Chronic Constipation
|
N/A | |
| Recruiting |
NCT03819062 -
Sacral Neuromodulation as Treatment for Chronic Constipation
|
N/A | |
| Completed |
NCT00730171 -
An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation
|
Phase 3 | |
| Completed |
NCT00765882 -
Phase III, Randomized, Double-Blind, Placebo-Controlled, Trial of Linaclotide Administered to Patients With Chronic Constipation
|
Phase 3 | |
| Completed |
NCT00354575 -
Effect of Chinese Herb on Chronic Constipation for Residents in Long-Term Care Units
|
Phase 2 | |
| Active, not recruiting |
NCT03119584 -
Efficacy of Linaclotide in Type II Diabetics With Chronic Constipation
|
Phase 4 | |
| Completed |
NCT00765999 -
An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation
|
Phase 3 | |
| Completed |
NCT01793753 -
Effect of Propofol on Internal Anal Sphincter Pressure During ARM
|
N/A | |
| Completed |
NCT00746200 -
Acupuncture for Chronic Constipation
|
Phase 3 | |
| Enrolling by invitation |
NCT00671684 -
Endoscopic Mucosal Resection (EMR) for Diagnosis of Hirschsprung's Disease
|
Phase 1/Phase 2 | |
| Completed |
NCT00391820 -
Evaluate the Safety and Efficacy of a 5-HT4 Agonist in Chronic Constipation (ACCORD Trial)
|
Phase 2 | |
| Completed |
NCT00404040 -
Movicol in Childhood Constipation (ProMotion Study)
|
Phase 2 | |
| Completed |
NCT02281630 -
Phase II Dose-Finding Study of KWA-0711 in Patients With Chronic Constipation (CC)
|
Phase 2 | |
| Completed |
NCT00256984 -
Study of Stapled Transanal Rectal Resection (STARR) Surgery in Refractory Constipation Associated With Obstructive Defecation Syndrome (ODS)
|
Phase 4 | |
| Recruiting |
NCT05192317 -
Administration of a Natural Molecular Complex in Functional Chronic Constipation
|
N/A | |
| Active, not recruiting |
NCT05202028 -
The Efficacy of Massage and Reflexology Applications in Children With Cerebral Palsy
|
N/A | |
| Completed |
NCT05734859 -
Drinking Effect of Electrolyzed Alkaline Reduced Water on Functional Constipation
|
N/A | |
| Completed |
NCT01007123 -
Study of A3309 in Patients With Chronic Idiopathic Constipation
|
Phase 2 | |
| Completed |
NCT00402337 -
Dose-range-finding, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Chronic Constipation
|
Phase 2 | |
| Completed |
NCT02961556 -
General Clinical Study of AJG555 in Pediatric Patients With Chronic Constipation
|
Phase 3 |